Get started
Author

Suryakanta Acharya

Observed names: S Acharya, S. Acharya
ORCID: 0000-0001-7792-0233
Observed ORCID: 0000-0001-7792-0233
OpenAlex ID: A5026237190
The global impact of the COVID-19 pandemic on delays and disruptions in cancer care services: a systematic review and meta-analysis
2025 · Richa Shah, Nader Mounir Hanna, et al. · Nature Cancer · 47
Global review of COVID-19 mitigation strategies and their impact on cancer service disruptions
2024 · Richa Shah, Ching Ee Loo, et al. · Journal of Cancer Policy · 6
PDF
Chemoradiation in locally advanced cervical cancer : A randomized trial
2008 · Sayan Kundu, S Basu, et al. · Indian Journal of Medical and Paediatric Oncology · 6
PDF
Breast cancer risk correlates with level of atypia in prophylactic mastectomy(PM) specimens
2004 · S. Kulkarni, A. Rademaker, et al. · Annals of Surgical Oncology · 2
In Regard to Bentzen et al
2026 · Suryakanta Acharya · International Journal of Radiation Oncology*Biology*Physics · 1
Is the PORTEC 4a trial exploring too little and too late?
2025 · Suryakanta Acharya · International Journal of Gynecological Cancer · 1
Abstract A083: Low dose abiraterone in prostate cancer - Safety, efficacy and pharmacoeconomic implications
2023 · Suryakanta Acharya · Cancer Research · 1
P48.14 Metastatic NSCLC -Re-Challenging With Fist Generation TKI After a Drug Free Holiday After Resistance to 3rd Generation TKI
2021 · S. Acharya · Journal of Thoracic Oncology · 1
Radiation-induced Hypothyroidism in Locally Advanced Breast Cancer
2026 · Suryakanta Acharya · OncoDaily Medical Journal
PDF
Financial Implications of Hypofractionated Radiotherapy in Locally Advanced Breast Cancer
2025 · Suryakanta Acharya · The Breast
Abstract C133: The missing cancer and palliative care in displaced community in Northeast India
2024 · Suryakanta Acharya · Cancer Epidemiology Biomarkers & Prevention
6 Impact of application parameters on isodose coverage of point a in cervix cancer brachytherapy
2024 · Suryakanta Acharya · International Journal of Gynecological Cancer
P03.01 Efficacy and toxicity of BCG therapy in bladder cancer
2024 · S Acharya · Poster presentations
PDF
Low dose abiraterone in prostate cancer - safety, efficacy and pharmacoeconomic implications
2023 · S. Acharya · European Urology Open Science
Po133 Radiation Induced Hypothyroidism in Locally Advanced Breast Cancer
2023 · Suryakanta Acharya · The Breast
#15 Bone marrow toxicity in pelvic chemoradiation
2023 · Suryakanta Acharya · International Journal of Gynecological Cancer
PDF
PO45 Presentation Time: 4:45 PM
2022 · Suryakanta Acharya · Brachytherapy
170P Safety, efficacy and pharmacoeconomic implications of low dose abiraterone in prostate cancer
2022 · S. Acharya · Annals of Oncology
Radiation cystitis after 21 years of pelvic radiation
2022 · Suryakanta Acharya
Palliative radiation in mCRPC – biochemical response and toxicity assessment
2022 · Suryakanta Acharya
EP14.03-004 Neuro-cognitive Effect of HS-PCI in LS-SCLC
2022 · S. Acharya · Journal of Thoracic Oncology
78P Breast cancer hypofractionated radiotherapy and its implications
2022 · S. Acharya · Annals of Oncology
PDF
Abstract PO-213: Financial implication of prostate cancer hypofractionated radiotherapy
2022 · Suryakanta Acharya · Cancer Epidemiology Biomarkers & Prevention
Regarding "Dosimetric predictors of acute bone marrow toxicity in carcinoma cervix - experience from a tertiary cancer centre in India" (Rohith Singareddy, Harjot Kaur Bajwa, Mahendra M. Reddy).
2022 · Suryakanta Acharya · PubMed
Role of hemi-body radiation in prostate cancer with disseminated bone metastasis in geriatric patients
2021 · S. Acharya · Journal of Geriatric Oncology
Works count: 27
Citation count: 65
H-index: 3
I10-index: 1
Year
Topic
Type